Login

Unlocking Nigerian Telecom Growth: Optiva's Role in Digital MVNO Success | Robert Stabile, CEO & Chairman of the Board at Optiva Inc 00:10:00

Share On Facebook Share On Twitter

Rob Stabile is Chairman/Interim CEO at Optiva Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Understanding the Peter Principle: How Promotions Can Lead to Incompetence | Michelle Smalenberger, CEO, Financial Design Studio.
00:00:00
Faron Pharmaceuticals outlines groundbreaking work in cancer treatment - Markku Jalkanen, CEO of Faron Pharmaceuticals Limited
00:10:00
GV originated as an independent venture capital firm for innovative founders|Andy Wheeler,General Partner,GV
00:10:00
Harmonizing Productivity: The Mori Keiichi of Focus System | Keiichi Mori , President of Focus Systems Corp
00:10:00
AdvTech Sees Continued Enrollment Growth Across Africa Amid High Demand for Quality Education | Roy Douglas, CEO, Advtech Ltd .
00:10:00
Lincoln Internship: Building Future Financial Planners
00:10:00
LPL Strategic Wealth Services: Empowering Advisors for Seamless Independence
00:10:00
Respect for the entrepreneur and the company-building process|Marc Andreessen,Investor, Andreessen Horowitz
00:10:00
Interview with Helmut Hotter, Director Controlling at A1 Telekom Austria AG, and Enpal Co-Founder Viktor Wingert on sustainability and business strategies.
00:10:00
Exploring Disruption in Banking Technology: Goh Peng Ooi's Insights from Finzsoft HQ | Goh Peng Ooi , Founder, Silverlake Axis Ltd.
00:10:00
Yuri Milner on Building DST Global and Investing in the Future | Yuri Milner, Founder, DST Global.
00:10:00
Piyush Gupta's Vision for DBS and Southeast Asia's Future | Piyush Gupta, CEO, DBS Group.

© 2017 - Neuhu+